Positive anticalcitonin immunoscintigraphy in patients with medullary thyroid carcinoma.

A cocktail of three monoclonal F(ab')2 fragments against three distinct epitopes of calcitonin or PDN 21 was labelled with either 111In or 131I. These F(ab')2 fragments, a control 125I-F(ab')2 fragment and 99mTc-pertechnetate were injected into four patients suffering from medullary thyroid carcinoma. Scintigraphy data were processed by energy factor analysis for an optimal separation of images corresponding to each isotope. The best tumor detection was obtained 1-3 days after injection of the 111In-F(ab')2 cocktail which clearly labeled the thyroid tumors in the four patients (smallest tumor detected, 0.6 cm) as well as lymph node and bone metastases. In the liver, positive detection was only successful with the 131I-labeled cocktail. These results were confirmed by counting rates of resected specimens which provided average specificity indices ranging from 3.3 to 13.1. Anticalcitonin antibodies could be particularly useful for immunoscintigraphy detection of residual or recurrent medullary thyroid carcinoma in patients with elevated calcitonin serum level.

[1]  B. Caillou,et al.  Construction and clinical validation of a sensitive and specific assay for serum mature calcitonin using monoclonal anti-peptide antibodies. , 1988, Clinica chimica acta; international journal of clinical chemistry.

[2]  J. Konishi,et al.  A new imaging agent for medullary carcinoma of the thyroid. , 1984, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[3]  D. Bellet,et al.  Radioiodination of human calcitonin using the Iodogen reagent. , 1986, Journal of immunological methods.

[4]  D. Pressman,et al.  The use of paired labeling in the determination of tumor-localizing antibodies. , 1957, Cancer research.

[5]  D. Bellet,et al.  Monoclonal antibodies distinguish synthetic peptides that differ in one chemical group. , 1987, Journal of immunology.

[6]  D. Barber The use of principal components in the quantitative analysis of gamma camera dynamic studies. , 1980, Physics in medicine and biology.

[7]  P. Fraker,et al.  PROTEIN AND CELL MEMBRANE IODINATION WITH A SPARINGLY SOLUBLE CHLOROAMIDE , 1978 .

[8]  N. Samaan,et al.  Localization of a radiolabeled monoclonal antibody to calcitonin in rat medullary thyroid carcinoma allografts. , 1987, Henry Ford Hospital medical journal.

[9]  C. Langlais,et al.  Tomoscintigraphy for detecting gastrointestinal and medullary thyroid cancers: first clinical results using radiolabelled monoclonal antibodies against carcinoembryonic antigen. , 1982, British medical journal.

[10]  K. Gautvik,et al.  Uptake and localization of 131I‐labeled anti‐calcitonin immunoglobulins in rat medullary thyroid carcinoma tissue , 1982, Cancer.

[11]  A. Tashjian,et al.  Medullary carcinoma of the thyroid gland. Studies of thyrocalcitonin in plasma and tumor extracts. , 1968, The New England journal of medicine.

[12]  J. P. Bazin,et al.  Handling of Dynamic Sequences in Nuclear Medicine , 1982, IEEE Transactions on Nuclear Science.

[13]  M. Karnovsky,et al.  THF EARLY STAGES OF ABSORPTION OF INJECTED HORSERADISH PEROXIDASE IN THE PROXIMAL TUBULES OF MOUSE KIDNEY: ULTRASTRUCTURAL CYTOCHEMISTRY BY A NEW TECHNIQUE , 1966, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[14]  D. Bellet,et al.  Evaluation of protocols for purification of mouse monoclonal antibodies. Yield and purity in two-dimensional gel electrophoresis. , 1986, Journal of immunological methods.

[15]  R. Perdrisot,et al.  Radioiodinated meta‐iodobenzylguanidine uptake in medullary thyroid cancer: A French cooperative study , 1987, Cancer.

[16]  J. Connell,et al.  Poor results with technetium-99m (V) DMS and iodine-131 MIBG in the imaging of medullary thyroid carcinoma. , 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[17]  R. L. Childs,et al.  Radioactive labeling of antibody: a simple and efficient method. , 1983, Science.

[18]  M. Tubiana,et al.  The values of calcitonin and carcinoembryonic antigen in the treatment and management of nonfamilial medullary thyroid carcinoma , 1983, Cancer.